The secreted protease ADAMTS18 is a novel activator of latent TGF-β to exacerbate renal fibrosis
Open Access
- 7 June 2025
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-20
Abstract
Renal fibrosis (RF) is an inevitable consequence of almost all forms of progressive chronic kidney disease (CKD). TGFβ is a powerful cytokine capable of dominating the fibrotic process. Targeting factors capable of activating latent TGF-β is a more effective and safe strategy to reduce TGF-β-induced fibrosis, but appropriate targets need to be identified. Here, we show that ADAMTS18/Adamts18 is significantly upregulated in the fibrotic kidneys of human CKD patients and mice. ADAMTS18 is primarily produced by renal tubular epithelial cells and fibroblasts during RF. Functionally, Adamts18 deletion inhibits epithelial-mesenchymal transition, inflammation, and collagen synthesis. Conversely, Adamts18 overexpression exacerbates progressive renal fibrosis. Mechanistically, the KPFR sequence in ADAMTS18 disrupts the latency-associated peptide (LAP) interaction with TGF-β and increases the release of mature TGF-β1. Blockage of ADAMTS18-mediated latent TGF-β activation by a tetrapeptide (LSKL) effectively reverses RF. Collectively, ADAMTS18 is a novel LAP-TGF-β1 activator with the potential to optimize CKD treatment strategies.Keywords
Funding Information
- National Natural Science Foundation of China (81170481)
This publication has 62 references indexed in Scilit:
- The secreted protease ADAMTS18 links early isoform transformation and maturation of glomerular basement membrane macromolecules to the integrity of the glomerular filtration barrierBiochemical and Biophysical Research Communications, 2025
- The progression of obstructive renal fibrosis in rats is regulated by ADAMTS18 gene methylation in the embryonic kidney through the AKT/Notch pathwayJournal of Biochemical and Molecular Toxicology, 2023
- From inflammation to renal fibrosis: A one-way road in autoimmunity?Autoimmunity Reviews, 2023
- Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal TransitionAdvanced Science, 2023
- Mouse Models of Kidney Fibrosis2021
- TGF‐β as a driver of fibrosis: physiological roles and therapeutic opportunitiesThe Journal of Pathology, 2021
- Collagen metabolism as a regulator of proline dehydrogenase/proline oxidase-dependent apoptosis/autophagyAmino Acids, 2021
- ADAMTS Proteins: Concepts, Challenges, and Prospects2019
- New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradationBiochemical Pharmacology, 2016
- LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstructionArchives of Pharmacal Research, 2010